AshiBio
PrivateLast Round
Series A
Jun 20, 2024
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AshiBio is a biotechnology company that develops innovative therapies aimed at preventing symptoms and slowing disease progression for patients with rare bone and connective tissue disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AshiBio Comparables
Compare AshiBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ipsen | 75% | |
| Mereo BioPharma Group plc | 72% | |
| SiSaf Ltd | 71% | |
AshiBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2024 |
Key People
Founding team and executive leadership
AshiBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series A |
| MPM BioImpact | Series A, Seed |
| Mirae Asset Venture Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 32% MoM, reaching 2K.
- Jun 20, 2024
$40M round with participation from Mirae Asset and Agent Capital.
AshiBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AshiBio's valuation, stock price, and market status.